Literature DB >> 16569478

High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.

Shuji Iwai1, Takashi Murai, Susumu Makino, Wei Min, Keiichirou Morimura, Satoru Mori, Atsushi Hagihara, Shuichi Seki, Shoji Fukushima.   

Abstract

The fatty liver Shionogi (FLS) mouse is a new inbred strain that spontaneously develops fatty liver with infiltration of mononuclear cells. Moreover, this mouse is known to frequently develop spontaneous hepatic cancers. Recently, human non-alcholic steatohepatitis (NASH) has been focused of attention regarding hepatocellular carcinoma. Therefore, this mouse has potential as a model for human hepatic cancer due to steatosis. It is of interest therefore, whether it exhibits elevated susceptibility not only regarding spontaneous tumor development but also to chemical hepatocarcinogens. To examine this concern, we examined diethylnitrosamine (DEN) hepatocarcinogenesis in FLS mice with 30ppm in drinking water for 26 weeks in comparison to two other strains of mice, C3H and C57. The induction of spontaneous and DEN-induced hepatic tumors was clearly increased in the FLS case, along with levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative DNA damage, as compared to the other strains, with or without DEN treatment. These results indicate that the oxidative DNA stress is intimately involved in hepatocarcinogenesis in FLS mice and provide further support for use of this mouse as a useful model for investigating hepatocarcinogenesis due to human hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569478     DOI: 10.1016/j.canlet.2006.02.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

2.  Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.

Authors:  Xiaojing Zhao; Qi Chen; Wei Liu; Yusang Li; Hebin Tang; Xuhan Liu; Xiangliang Yang
Journal:  Int J Nanomedicine       Date:  2014-12-30

3.  Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.

Authors:  Ming Tong; Alexander Neusner; Lisa Longato; Margot Lawton; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  Long-term Branched Chain Amino Acid Supplementation Ameliorates Diethylnitrosamine-induced Liver Glutathione S-transferase-p Positivity in Zucker Fatty Rats.

Authors:  Sonoko Ishizaki; Megumi Nishiyama; Asami Hagiwara
Journal:  J Clin Exp Hepatol       Date:  2013-09-06

5.  Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice.

Authors:  Le Thi Thanh Thuy; Takashi Morita; Kayo Yoshida; Kenichi Wakasa; Masashi Iizuka; Tomohiro Ogawa; Mami Mori; Yumiko Sekiya; Shinobu Momen; Hiroyuki Motoyama; Kazuo Ikeda; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

Review 6.  Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Alexander Neusner; Jennifer Chu; Margot Lawton
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver.

Authors:  Mutsuko Minata; Kouji H Harada; Anna Kärrman; Toshiaki Hitomi; Michi Hirosawa; Mariko Murata; Frank J Gonzalez; Akio Koizumi
Journal:  Ind Health       Date:  2010       Impact factor: 2.179

9.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

10.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.